An in-depth overview of Hinge Health Inc., outlining its digital musculoskeletal care platform, operational model, and role ...

SAN FRANCISCO, November 12, 2025--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. "During the first ...

San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming ...

A 12-week, 177-participant trial of Hinge Health’s at-home digital program for chronic pain relief significantly reduced users’ lower back pain, disability and interest in surgery. The study, led by ...

SAN FRANCISCO, November 24, 2025--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer ...

Hinge Health’s s-1 filing seems to shed a light on DarioHealth’s potential opportunity; With Hinge targeting a potential $3-6B IPO valuation with similar growth metrics, Dario’s comparable 32.9% ...

Based in San Francisco, Hinge Health has developed a digital platform that employs artificial intelligence to largely automate the treatment of joint and muscle conditions. The platform is designed to ...

Shares of California-based Hinge Health, Inc. (HNGE) jumped 19% above its initial public offering price on Thursday in its debut on the New York Stock Exchange (NYSE). Shares of the company, which ...

SAN FRANCISCO - Hinge Health, Inc. (NYSE:HNGE) announced on November 10 that its board of directors has authorized a $250 million share repurchase program for its outstanding Class A Common Stock. The ...